Nov. 29, 2021 -- Merck’s antiviral tablet for COVID-19, molnupiravir, appears to be much significantly less effective than early success...
Nov. 29, 2021 -- Merck’s antiviral tablet for COVID-19, molnupiravir, appears to be much significantly less effective than early success...
WhatsApp us